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ABSTRACT
Purpose: With the improved macro- and micro-designs, dental implants enjoy a high survival rate. However, peri-implant
bone loss has recently emerged to be the focus of implant therapy. As such, researchers and clinicians are in need of finding
predictable techniques to treat peri-implant bone loss and stop its progression.
Materials and Methods: Literature search on the currently available treatment modalities was performed and a brief
description of each modality was provided.
Results: Numerous techniques have been proposed and none has been shown to be superior and effective in managing
peri-implant bone loss. This may be because of the complex of etiological factors acting on the implant-supported
prosthesis hence the treatment approach has to be individually tailored.
Conclusion: Due to the lack of high-level clinical evidence on the management of peri-implant bone loss, the authors,
through a literature review, attempt to suggest a decision tree or guideline, based on sound periodontal surgical principles,
to aid clinicians in managing peri-implantitis associated bone loss.
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INTRODUCTION
Retention of a tooth is often an ideal clinical scenario;
however, when its long-term prognosis is hopeless, both
the patient and clinician are faced with the challenges
associated to have it replaced. In these instances, several
options are available, such as fabricating a removable
partial denture, a fixed partial denture, or an implant-
supported prosthesis (ISP). Considering the high
success or survival rates of dental implants, it is often the
preferred choice of treatment.1–4 Unfortunately, dental
implants are not miracle tooth replacements and
with the increased rate of implant placement, having
knowledge in the management of implant complica-
tions is very crucial.
According to the International Congress of Oral
Implantologists Pisa Consensus Conference report,
implant failure refers to implants that were lost or
removed.5 The authors of this report suggested that the
term “failure” can be applied to an implant, which has
pain on function, mobility, radiographic bone loss
greater than half of the implant length, uncontrolled
exudates, or if it is no longer in the mouth.5 The term
“implant complication”, on the other hand, is applied
when there is an unexpected deviation from the stan-
dard treatment outcome,6 and further treatment is
required after delivery of the prosthesis.7
One of the most challenging implant complications
to deal with is peri-implantitis, which is defined as a
localized lesion involving bone loss around an osseoin-
tegrated implant.5 Various studies published in the last 8
years (2003–2011) looked at the success and survival
rates of dental implants after at least 10 years of func-
tional loading and found that the mean survival rate
ranged from 89% to 95%.8–13 Despite the high long-term
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survival rates, dental implants are plagued with biologi-
cal and mechanical complications. A systematic review
of 51 prospective longitudinal studies reported an inci-
dence of peri-implantitis ranging from 0% to 14.4%
around functional implants with a minimum of 5 years
follow-up.14 Other longitudinal studies, on the contrary,
found substantial variation in the prevalence of peri-
implantitis, ranging from 11.3% to 47.1%8,15–17 and
a cumulative complication rate of 48.03% after a
follow-up period of 10–16 years was observed.8
Peri-implantitis can be caused by mechanical18 or
biological19 factors. Occlusal overloading is a common
mechanical complication that results from an interplay
of several factors including poor prosthetic design,20
inadequate number, dimensions and distribution of
implant fixtures,21 non-ideal implant positions,22 and
parafunctional habits of patients.23,24 The clinical conse-
quences of which are fractures of implant fixture, abut-
ment screws, prostheses and their attachments and
acrylic resin or ceramic veneers, prosthesis or abutment
screw loosening, early or late implant failure, and peri-
implant marginal bone loss.25
Similar to periodontitis, microbial pathogens in
dental plaque is the main biological cause of peri-
implantitis.26 It was found that supra- and sub-gingival
biofilms in sites with peri-implantitis had higher counts
of red complex periopathogens such as Porphyromonas
gingivalis, Treponema denticola, and Tannerella for-
sythia.27,28 In addition, the number of beneficial
microbial complexes was reduced.27 Thus, creating an
environment favorable for progressive bacterial-induced
peri-implant marginal bone loss. Other environmental
and patient-related factors may contribute to peri-
implant bone loss. For example, smoking was found to
be a potent risk factor that adversely affects implant
success and survival rates.29,30 Patient-related factors
such as systemic diseases like uncontrolled diabetes,31,32
age,33 gender,34 and history of periodontitis34,35 have
been shown to contribute to peri-implant bone loss.
Other biological factors include compression necrosis,36
infection,37 and overheating of the bone during implant
site preparation.38
With the loss of supporting bone around a dental
implant, patients may have to face the eventual conse-
quence of implant loss. This translates to the loss of
quality of life, function, esthetics, time, and money,
which can also cause psychosocial stress on the
patients.39–43 As such, managing peri-implant bone loss
has become the focus of many researchers, and several
studies have been conducted to find the optimum treat-
ment with a goal of achieving reosseointegration along
the previously contaminated implant surface.44–46 This
article is aimed at discussing the effect of guided bone
regeneration (GBR) in the management of peri-implant
bone loss. A decision tree based on current evidence was
proposed by authors to serve as a guide for clinicians to
follow when managing peri-implant bone loss.
PERIODONTAL DEFECTS VERSUS
PERI-IMPLANT DEFECTS
Periodontal defects can be categorized into suprabony,
intrabony, or inter-radicular defects.47 They have been
commonly described by the number of osseous walls,
which is 4-walls or circumferential, 3-walls, 2-walls,
1-wall, or combination defects.48 The number of
osseous walls surrounding the defect serves as an
indication of the regenerative potential of the site.49
In natural dentition, intrabony defects frequently
develop in posterior interproximal surfaces.50 Peri-
implant defects, on the other hand, are mainly com-
bined defects that have supracrestal and intrabony
components, with 55% of them being circumferential
defects.51 A review on surgical treatment of peri-
implant defects concurred that peri-implant defects
were well-demarcated craters.52
Different research groups have adopted the concept
from periodontal defects and attempted to classify peri-
implant defects based on the number of remaining
osseous walls. In a retrospective study of 75 patients with
peri-implantitis, no or 1-wall defects corresponded to
having less than 33% of surrounding bone, 2-wall
defects had 33–67% of surrounding bone, and 3-wall
defects had more than 67% of surrounding bone.53
Using human and animal peri-implantitis models,
Schwarz and colleagues classified peri-implant osseous
defects into two main categories: Class I being intrabony
defects with five subcategories of class 1a to 1e, and class
II being suprabony defects.51 Class 1a is dehiscence type
defect, class 1b has buccal and interproximal bone loss,
and class 1c is an extension of class 1b defects with bone
loss on the lingual side of the implant. Class 1d has
buccal and lingual dehiscences and interproximal bone
loss and, lastly, class 1e is a well-defined circumferential
defect.51 Similar to 4-wall periodontal osseous defects, it
was found that class 1e defects had the greatest regen-
erative potential.51,54
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AVAILABLE TREATMENT MODALITIES
Given the similarities between periodontitis and peri-
implantitis, treatment modalities proposed for the man-
agement of peri-implantitis emulate techniques used to
treat periodontitis. These techniques can be broadly
classified into nonsurgical (e.g., antimicrobial therapy
and mechanical debridement), surgical (e.g., surgical
debridement, implantoplasty, and dental lasers), and
regenerative therapies (e.g., GBR) with common goals of
eliminating infection and restoring lost structures and
function.
Nonsurgical Therapy
Human clinical trials demonstrated that locally deliv-
ered tetracycline combined with nonsurgical debride-
ment in peri-implantitis sites improved clinical and
microbiological parameters. However, the radiographic
bone fill reported as 6%55 and 0.2–0.3 mm56 was clini-
cally insignificant. Mechanical nonsurgical treatment
was also found to be ineffective in the management of
peri-implantitis lesions in various reviews and clinical
trials.57–60 Therefore, surgical and regenerative treatment
modalities were generally preferred.
Surface Decontamination
The goals of surface decontamination are to remove
etiological factors, for example, pathogenic bacteria and
create a pristine surface for reosseointegration. Several
agents including saline,61 abrasive pumice,62 citric
acid,63 chlorhexdine,64 air-power abrasive,65 hydrogen
peroxide,66 and antimicrobials66 have been used for
surface decontamination in the surgical management of
peri-implantitis lesions but no agent was found to be
superior. Animal studies evaluating the efficacy of del-
mopinol,67 abrasive pumice, and saline62 showed that
despite resolution of peri-implantitis, reosseointegra-
tion was not achieved. It was only when the coronal
component of the implant was replaced that new bone
formation was observed to be in contact with the newly
placed implant part.61 A recent randomized controlled
clinical trial failed to show a significant impact of
surface decontamination in the treatment of peri-
implantitis.68 However, surface decontamination with
surgical debridement was found to have a favorable
influence on reosseointegration in a systematic
review.45
Dental lasers and photodynamic therapy have been
used in the decontamination of implant surfaces during
surgical and regenerative treatment of peri-implantitis
lesions. Carbon dioxide laser was found to be effective in
eliminating bacterial pathogens, specifically Streptococ-
cus sanguis and Porphyromonas gingivalis, from titanium
implant surfaces without causing surface alterations,
rising the temperature or even inhibiting cell adhesion
to the irradiated area.69 Similar results were found by
other researchers utilizing Nd:YAG,70 Er:YAG71 and
diode72 lasers. Laser therapy in combination with bone
graft and collagen membrane achieved “almost com-
plete” bone fill in the peri-implant defect.73,74 However,
the long-term benefits of laser assisted treatment of
peri-implant defects was not significant.68,75
Implantoplasty is also a form of surface decontami-
nation as it involves eliminating the implant threads to
achieve a smooth polished surface to decontaminate and
reduce the ability of plaque to adhere to the implant
surface.76,77 There are several clinical difficulties associ-
ated with implantoplasty, namely an increase in tem-
perature generated when drilling, which might injure
the surrounding tissues and affect the strength of the
implant,78 scattering of the metallic debris that might get
embedded in the tissue and reduced esthetic outcome. It
was found that if premium diamond burs were used
with adequate coolants, there was only a 1.5°C increase
in temperature, which was not damaging for the sur-
rounding tissues.79 The use of a rubber dam to isolate
the implant from the surrounding tissues and a high
vacuum suction would minimize scattering of the
metallic debris.
Surgical Debridement
Results of a recent systematic review from 25 animal
studies showed that open debridement combined with
surface decontamination of implants might result in
reosseointegration, which was also found to be more
pronounced on rougher surfaces compared with
smooth surfaces.45 However, it was concluded that none
of the different techniques used in managing contami-
nating implant surfaces was able to achieve a complete
reosseointegration along the treated implant surface.
Regenerative Procedures
Human studies80,81 have been carried out to evaluate the
effects of regenerative procedures in the treatment of
peri-implantitis. Surgical reentry examinations showed
that GBR resulted in the highest new bone fill, followed
by bone grafts alone, and flap debridement only.
Current Understanding of Peri-Implant Bone Loss e111
However, no significant difference was found between
GBR and GBR combined with bone graft.82 The results
were confirmed by a subsequent study revealing similar
and more detailed histological findings.83
A recent systematic review revealed that GBR could
be used in the management of peri-implant bone
loss, but complete fill of the bony defect was not
predictable.84 Several limitations such as heterogeneity
of the study protocols, missing data, and lack of high-
quality studies were highlighted in the review.84 Previous
reviews too found that regenerative procedures involv-
ing bone grafts with or without barrier membranes
demonstrated varying degrees of defect resolution and
could possibly be one of the more predictable treatment
modality in selected cases of peri-implantitis.85,86 There-
fore, in the proposed guideline, GBR was chosen as the
main treatment modality in the management of peri-
implant bone loss.
DECISION TREE
Current literature discussed numerous techniques used
in the management of peri-implantitis defects. However,
because of limitations in the available systematic
reviews, there is no consensus on the most effective way
to treat peri-implant bone loss.87 The authors thus
propose a decision tree to assist clinicians in deciding the
treatment modality to use when faced with a peri-
implant bone defect (Figure 1). Similar to periodontal
defects, the first step in managing peri-implant defects is
to identify and remove the etiological factors, which can
be classified into biological factors, biomechanical
factors, and a combination of both factors. Unfortu-
nately in some circumstances, elimination of etiological
factors involves removal of the dental implant. For
example, when the implant is placed out of the buccal
bony housing, regeneration of the buccal bone and
APF with
implantoplasty
1 2 3
GBR with either
absorbable or non-
resorbable membranes
Within bony
housing
(Ideal implant
position)
Outside
bony
housing
Remove the
implant and
perform hard and
soft tissue
augmentation
Peri-implant bone loss
Biomechanical
E.g. Wrong position, occlusal
overload or interference
Biological 
E.g. Microbial (peri-implantitis), compression
necrosis, surgical trauma (such as overheating,
overpreparation)
Combination
Defect morphology
Remove etiology
Etiology 
Horizontal Vertical Circumferential 
APF with
implantoplasty
Number of
bony walls
Check occlusion and
implant position
GBR
Figure 1 Decision tree on etiology and management of peri-implant bone loss. APR = apically positioned flap; GBR = guided bone
regeneration.
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maintenance of its stability under functional loading is
highly unpredictable. Therefore, removal of the implant
and performing both hard and soft tissue augmenta-
tions would help in rebuilding the edentulous ridge for
the placement of another implant. If mechanical over-
load is the cause of peri-implant bone loss, adjustment
of occlusion or changing the prosthesis might alleviate
the occlusal trauma on the surrounding bone, hence
removing the biomechanical causative factor (Figure 1).
Nonsurgical therapy is commonly part of initial
phase therapy with the primary goal of eliminating or
reducing peri-implant inflammation and bone loss.
A double-blind randomized longitudinal clinical study
showed that mechanical nonsurgical treatment of peri-
implantitis, either with titanium hand instruments or
with ultrasonic device, although improved plaque and
bleeding scores, both approaches had no effect on
probing implant pocket depths and total bacterial
count.58 The inability of nonsurgical approach to elimi-
nate bacteria was further supported by another single-
blinded randomized longitudinal study.88 From these
results, one can conclude that mechanical nonsurgical
therapy alone is not effective in managing the peri-
implantitis, and surgical treatment remains the pre-
ferred approach.
Similar to the treatment of periodontal defects,
peri-implant defects can be categorized into horizontal,
vertical, and circumferential defects. The management
of these defects is based on the principles set out by
Ochsenbein 25 years ago.89 The lack of clinical evidence
suggested that achieving bone regeneration and
reosseointegration in horizontal bone defects is unpre-
dictable. Therefore, the authors proposed performing an
apically positioned flap to reduce peri-implant probing
pocket depths and facilitate the formation of a more
aerobic and less pathogenic biofilm.90 However, many
systems have moved to a roughened implant surface
possibly because of a more predictable and stable bone
to implant relationship.91,92 Therefore, once these rough-
ened surfaces are exposed to the oral environment, there
is a significant increase in surface area available for
plaque retention that may influence the health of peri-
implant tissues. As such, the authors proposed perform-
ing implantoplasty to create a smooth surface that is less
plaque retentive, thus slowing down the progression of
peri-implant bone loss.76
The regenerative potential of vertical defects is
dependent on several factors, namely patient-related
factors such as oral hygiene93 and smoking,94 systemic
conditions such as uncontrolled diabetes,95 and defect
related factors such as extent of bone loss, number of
defect walls, width and depth of defect.96 Patients with
good oral hygiene have a reduced quantity of bacterial
insults, which implies a lowered progression of the
breakdown of peri-implant tissues. In addition, good
oral hygiene is beneficial in achieving and maintaining
disease resolution.93 Smoking has been associated with
reduced bone regeneration because of a decrease in
angiogenesis and blood flow to the regenerative site.97 In
addition, there is a negative effect on epithelial prolif-
eration and healing resulting in an increased in flap
dehiscence and incision line opening.98 Uncontrolled
diabetes mellitus results in hyperglycemia, which
adversely affects osteoblast proliferation and collagen
turnover. Combined with increased osteoclastic action
and release of pro-inflammatory cytokines, there is
more bone resorption than bone formation resulting in
bone loss.95 Therefore, prior to performing GBR in peri-
implantitis lesions, it is beneficial to have all patient-
related factors under control.
The authors chose the number of defect walls as the
primary determining factor in the management of ver-
tical peri-implant bone defects after considering surgical
principles proposed by Ochsenbein89 and Cortellini and
Tonetti.96 An apically positioned flap with implanto-
plasty for 1-wall peri-implant bone defects is suggested
because of its reduced potential to regenerate. Two- and
3-wall peri-implant bone defects have higher regenera-
tive potential; therefore, GBR is recommended.99,100 In
2-wall defects, the bone graft will be placed in a non-
contained site, therefore a non-resorbable membrane,
for example, ePTFE or PTFE, will be a more suited
choice as it can hold and maintain space for extended
periods of time. In 3-wall defects, the bone graft will be
contained within the bony walls, hence an absorbable
membrane will be sufficient.
Circumferential defects are commonly seen around
dental implants and believed to be caused primarily by
occlusal overloading as found around the natural denti-
tion that are subjected to trauma from occlusion. In
these cases, it is important to relieve heavy occlusal con-
tacts when the ISP is under axial and non-axial loading.
The implant position within the arch is also of para-
mount importance as it determines the feasibility of
bone regeneration around the implant.101 If the implant
position is not ideal, it is recommended to have the
Current Understanding of Peri-Implant Bone Loss e113
implant removed and the site regrafted with bone grafts
and soft tissue grafts. The implant will be placed after
the grafts have healed. When the implant is determined
to be in an ideal three-dimensional position, the circum-
ferential peri-implant bone defect can be regenerated
with GBR. The use of a non-resorbable or absorbable
membrane will suffice.
Following the “PASS” principle, where primary
wound closure is paramount in ensuring a stable
protected environment for optimal bone regeneration, it
would be ideal that the suprastructures, for example, the
abutment and prosthesis were removed and the regen-
erative site was left to heal under a closed environ-
ment.102 Removal of the suprastructures might prove to
be a challenge for cemented prosthesis, and alternatives
available are fabrication of a new prosthesis or conver-
sion of the cemented prosthesis to a screw retained one.
The inability to achieve primary wound closure around
a restoration provided a pathway for bacteria or foreign
bodies to reach the regenerative site resulting in com-
promised bone regeneration.103,104
Although the treatment and resolution of peri-
implantitis remains highly unpredictable with the
current available treatment options, some studies had
demonstrated promising results.60,84,87 In the light of
the studies reviewed, open debridement and regenera-
tion procedures have, by far, shown to demonstrate
superior and more consistent results compared with
the other currently available treatment modalities.
Antimicrobial therapy and surface decontamination
were shown to resolve peri-implantitis but they failed
to achieve significant reosseointegration, which was
the main goal of the treatment. In addition, most of
the studies available used antimicrobial followed by
mechanical debridement and local or systemic antibi-
otics administration, making it difficult to conclude the
true individual effectiveness of antimicrobial therapy
or surface decontamination. More randomized con-
trolled studies should be conducted to assess the effi-
cacy and the exact benefit of the available treatment
options. Future research should be directed at deter-
mining a standard optimum treatment for more pre-
dictable reosseointegration. The inconsistency of the
results in different studies could be due to the great
variability in methodologies, measured parameters,
implant design, surface characteristics of implants,
ligatures placement and removal time period, defect
morphology, and defect size. Until more evidence is
available, the use of antimicrobial therapy, or using one
decontamination agent over the other is not really
strongly supported. With the current lack of sufficient
and consistent documentation, especially lack of
human studies, a single best treatment cannot be
pointed out. Therefore, it is very important to highlight
the necessity of regular maintenance visits to monitor
the progression of disease and the effectiveness of
therapy. If peri-implant bone loss takes place, the
decision of treatment should be based on a patient-
by-patient situation. Hence, the authors suggested a
straightforward decision tree to provide clinicians a
reference when dealing with peri-implant bone loss.
CONCLUSION
Over the past 20 years, dentistry saw a paradigm shift in
the management of patients with missing teeth with the
introduction of dental implants. Today, seeking a pre-
dictable method to treat peri-implant bone loss and
achieve reosseointegration is the latest advancement in
implant dentistry. Although it is known that peri-
implant bone loss is caused by biological, biomechani-
cal, or a combination of factors similar to periodontal
disease around teeth, the predictability of treatment
modalities to manage these defects remains uncertain.
Numerous methodologies have been proposed over
time to treat peri-implant bone loss and retard its pro-
gression; however, there is no consensus on which tech-
nique is the most effective. Therefore, the authors,
through a literature review, suggest a straightforward
decision tree to help clinicians manage peri-implant
bone loss.
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